30JUN

Welcome To MJPPS

The editors welcome the submission of relevant articles for editorial consideration. Manuscripts should be addressed to editor@medjpps.com.

Mediterranean Journal of Pharmacy and Pharmaceutical Sciences
https://ppj.org.ly/article/doi/10.5281/zenodo.15381077

Mediterranean Journal of Pharmacy and Pharmaceutical Sciences

Original article

Correlational study of vitamin D deficiency and dyslipidemia among adult Libyan population

Apoajela A. Ahmed, Ashraf A. Alapid, Zohour M. Ahmed, Nor N. J. Moudah, Hadeel M. Salim

Downloads: 0
Views: 218

Abstract

Vitamin D deficiency is a public health concern affecting many individuals as it is highly prevalent in all parts of the world. Recent studies have reported an association of vitamin D deficiency with cardiometabolic alterations such as dyslipidemia. The study aimed to evaluate vitamin D and lipid profile levels among the Libyan adult population and investigate the correlation of vitamin D deficiency with the alteration of lipid profile levels. A cross-sectional study was conducted at Janzour Hospital among 193 subjects (107 males and 86 females) whose ages ranged between 20 and 50 years over three months from Sept to Dec 2023. Vitamin D, cholesterol, triglyceride, low-density lipoprotein, and high-density lipoprotein levels were estimated. The total mean vitamin D levels were 8.31±4.74, 23.83±2.78, and 42.67±7.95 ng/dl for deficiency, insufficiency, and sufficiency, respectively. The findings revealed significant alterations in cholesterol (increase), triglyceride (increase), LDL-cholesterol (increase), and HDL-cholesterol (decrease) among subjects who had vitamin D deficiency or insufficiency as compared to subjects having vitamin D sufficiency. Vitamin D levels were negatively correlated with cholesterol, triglyceride, and LDL cholesterol, and they were positively associated with HDL cholesterol. The incidence of dyslipidemia is higher in the vitamin D deficiency group than in the insufficiency and sufficiency groups. It is essential to frequently monitor lipid profiles among vitamin D-deficient individuals to avoid subsequent disorders or damages associated with the alterations of lipid profile patterns.

Keywords

Deficiency, insufficiency, lipid profile, sufficiency, vitamin D

References

  1. Anaiz N (2010) Rediscovering vitamin D. Libyan Journal of Medicine. 5 (1): 1-7. 5648. doi: 10.3402/ljm.v5i0.5648
  2. Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G (2018) Vitamin D deficiency and risk of cardiovascular diseases: A narrative review. Clinical Hypertension. 24: 1-9. doi: 10.1186/s40885-018-0105-5 
  3. Heaney RP (2008) Vitamin D in health and disease. Clinical Journal of the American Society of Nephrology. 3 (5): 1535-1541. doi: 10.2215/CJN.01160308
  4. Griz LHM, Bandeira F, Gabbay MAL, Dib SA, Carvalho EF de (2013)Vitamin D and diabetes mellitus: an update 2013. Arquivos Brasileiros Endocrinologia e Metabologia. 2014 Feb;58(1):1-8. doi: 10.1590/0004-2730000002535
  5. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffmann K (2014) A systematic review of vitamin D status in populations worldwide. The British Journal of Nutrition. 111 (1): 23-45. doi: 10.1017/ S0007114513001840
  6. Naeem Z, AlMohaimeed A, Sharaf FK, Ismail H, Shaukat F, Inam SNB (2011) Vitamin D status among population of Qassim region, Saudi Arabia. International Journal of Health Sciences. 5 (2): 116-124. PMID: 23267289.
  7. Alsuwadia AO, Farag YM, Al Sayyari AA, Mousa DH, Alhejaili FF, Al-Harb, AS, Housawi AA, Mittal BV, Singh AK (2023) Prevalence of vitamin D deficiency in Saudi adults. Saudi Medical Journal. 34 (8): 814-818. PMID: 23974452.
  8. Ahmed A, Amr M, Almoner B, Salim M, Abudaber S (2023) Evaluation of vitamin D status among adult population in Tripoli Region, Libya. AlQalam Journal of Medical and Applied Science. 6 (2): 626-634. doi: 10.5281/zenodo. 10005076
  9. Younis MYG (2024) Prevalence of vitamin D deficiency in Libya and its relation to other health disorders. Metabolism and Target Organ Damage. 4 (13): 1-21. doi: 10.20517/mtod.2023.36
  10. Holman A, Kurouski D (2023) The effects of sun exposure on colorant identification of permanently and semi-permanently dyed hair. Scientific Reports. 13: 2168. doi: 10.1038/s41598-023-29221-8
  11. Calvo MS, Whiting SJ, Barton CN (2005) Vitamin D intake: A global perspective of current status. The Journal of Nutrition. 135 (2): 310-316. doi: 10.1093/jn/135.2.310
  12. Alssageer MA, Alaasswad NM, Jebril AI, Ahmed HA, Almahdi RS (2022) Knowledge, attitude, and practice of Libyan medical students about vitamin D deficiency. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2 (3): 46-56. doi. 10.5281/zenodo.7115292
  13. Need AG, O’Loughlin PD, Horowitz M, Nordin BEC (2005) Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clinical Endocrinology. (Oxf). 62 (6): 738-741. doi: 10.1111/j.1365-2265.2005.02288.x
  14. de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, Lavie CJ, Sanchis-Gomar F, Pareja-Galeano H (2021) Vitamin D and cardiovascular health. Clinical Nutrition. 40 (5): 2946-2957. doi: 10.1016/j.clnu.2020.12.025
  15. Walli RR, Drbal AA, Altabib MN (2024) Body mass index and vitamin D in Libyan women. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 4 (2): 64-68. doi: 10.5281/zenodo.12171291
  16. Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, Song Y, Lim JH, Kim HJ, Choi S, Moon MK, Na JO, Park KY, Oh MS, Han SY, Noh J, Yi KH, Lee SH, Hong SC, Jeong IK (2019) Guidelines for the management of dyslipidemia in Korea. Journal of Lipid and Atherosclerosis. 8 (2):78-131. doi: 10.12997/jla.2019.8.2.78
  17. Okui T (2020) An age-period-cohort analysis of prevalence and consultation rate for dyslipidemia in Japan. Asia Pacific Journal of Public Health. 33 (1): 46-52. doi: 10.1177/1010539520963643
  18. Lacy M, Atzler D, Liu R, De Winther M, Weber C, Lutgens E (2019) Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis. Pharmacology and Therapeutics. 193: 50-62. doi: 10.1016/j.pharmthera.2018.08.012
  19. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Ärnlöv J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, Bärnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castañeda-Orjuela CA, Castillo-Rivas J, Catalá-López F, Choi JY, Christensen H, Cirillo M, Cooper L Jr, Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan GF, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA, Malekzadeh R, Mazidi M, Meier T, Meles KG, Mensah G, Meretoja A, Mezgebe H, Miller T, Mirrakhimov E, Mohammed S, Moran AE, Musa KI, Narula J, Neal B, Ngalesoni F, Nguyen G, Obermeyer CM, Owolabi M, Patton G, Pedro J, Qato D, Qorbani M, Rahimi K, Rai RK, Rawaf S, Ribeiro A, Safiri S, Salomon JA, Santos I, Santric Milicevic M, Sartorius B, Schutte A, Sepanlou S, Shaikh MA, Shin MJ, Shishehbor M, Shore H, Silva DAS, Sobngwi E, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadele Atnafu N, Tesfay F, Thakur JS, Thrift A, Topor-Madry R, Truelsen T, Tyrovolas S, Ukwaja KN, Uthman O, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Watkins D, Weintraub R, Werdecker A, Westerman R, Wiysonge CS, Wolfe C, Workicho A, Xu G, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Vos T, Naghavi M, Murray C (2017) Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of American College of Cardiology. 70 (1): 1-25. doi: 10.1016/j.jacc.2017.04.052
  20. Bansilal S, Castellano JM, Fuster V (2015) Global burden of CVD: focus on secondary prevention of cardiovascular disease. International Journal of Cardiology. 201 (1): S1-S7. doi: 10.1016/S0167-5273(15)31026-3
  21. Nowbar AN, Gitto M, Howard JP, Francis, DP, Al-Lamee R (2019) Mortality from ischemic heart disease. Circulation: Cardiovascular Quality and Outcomes. 12 (6): e005375. doi: 10.1161/CIRCOUTCOMES.118.005375
  22. Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL (2021) Global epidemiology of dyslipidaemias. Nature Reviews: Cardiology.18 (10): 689-700. doi: 10.1038/s41569-021-00541-4
  23. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 96: 1911-1930. 1911-30. doi: 10.1210/jc.2011-0385
  24. Zhang R, Naughton DP (2010) Vitamin D in health and disease: current perspectives. Nutrition Journal. 9: 65. 1-13. doi: 10.1186/1475-2891-9-65
  25. Ansari SA, Boker RA, Alsaid MS, Sherif RF, Sherif FM (2022) Analysis of the association of vitamin D3, hemoglobin and ferritin with special respect to Libyan patients. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2 (4): 1-5. doi: 10.5281/zenodo.7479667
  26. Alaasswad NM, Jebril AI, Ahmed HA, Almahdi RS, Alssageer MA (2022) Vitamin D deficiency and anemia among pharmacy students. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2 (2): 88-94. doi: 10.5281/zenodo.6780515
  27. Gaziano TA (2022) Cardiovascular Diseases Worldwide. In: Public Health Approach Cardiovascular Disease Prevention and Management. 1st ed., 8-18. ISBN: 9781003352686.
  28. Elmiladi SA, Elgdhafi EO (2023) Prevalence of cardiovascular risk factors in Libyan patients with type 2 diabetes mellitus, 2013-2022. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 3 (2): 27-33. doi: 10.5281/ zenodo.7877416
  29. Alssageer MA, Sherif FM, Mohammed ES, Abd Alsalm SA (2022) Patterns of drug-prescribed and drug-related problems among hospitalized elderly patients. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2 (2): 64-76. doi: 10.5281/zenodo.6780506
  30. Berberich AJ, Hegele RA (2022) A modern approach to dyslipidemia. Endocrine Review. 43 (4): 611-653. doi: 10.1210/endrev/bnab037
  31. Wen J, Huang Y, Lu Y, Yuan H (2019) Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population. Hypertension Research. 42 (8):1223-1230. doi: 10.1038/s41440-019-0251-5
  32. Msalati AA, Bashein A, Aljaloh E, Murad G, Sedaa K, Zaid A (2024) Prevalence of vitamin D deficiency in medical students. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2 (1): 69-78. doi: 10.5281/zenodo. 6399784
  33. Alapid A, Ahmed A, Wana M, Shadi M (2024) Hypomagnesaemia and relationship lipid profile in Type 2 diabetes patients at Janzur Hospital in Libya. AlQalam Journal of Medical and Applied Science. 7 (4): 973-979. doi: 10.54361/ajmas.247410
  34. Chaudhuri JR, Mridula KR, Anamika A, Boddu DB, Misra PK, Lingaiah A, Balaraju B, Bandaru VS (2013) Deficiency of 25‐hydroxyvitamin d and dyslipidemia in Indian subjects. Journal of Lipids. 2013: 623420. doi: 10.1155/2013/623420
  35. Abbas MA (2017) Physiological functions of Vitamin D in adipose tissue. The Journal of Steroid and Biochemistry and Molecular Biology. 165 (Pt B): 369-381. doi: 10.1016/j.jsbmb.2016.08.004
  36. Chiu KC, Chu A, Go VLW, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. The American Journal of Clinical Nutrition. 79 (5): 820-825. doi: 10.1093/ajcn/79.5.820
  37. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA, Kreisberg R, Goldberg R (2012) American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocrine Practice. 18 (1S): 1-78. doi: 10.4158/EP.18.S1.1
  38. Thompson PD, Myerburg RJ, Levine BD, Udelson JE, Kovacs RJ (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 8: coronary artery disease: A scientific statement from the American Heart Association and American College of Cardiology. Journal of the American College of Cardiology. 66 (21): 2406-2411. doi: 10.1016/j.jacc.2015.09.040
  39. Glueck CJ, Jetty V, Rothschild M, Duhon G, Shah P, Prince M, Lee K, Goldenberg M, Kumar A, Goldenberg N (2016) Associations between serum 25-hydroxyvitamin D and lipids, lipoprotein cholesterols, and homocysteine. North American Journal of Medical Science. 8 (7): 284-90. doi: 10.4103/1947-2714.187137
  40. Choi HS, Kim K-A, Lim C-Y, Rhee SY, Hwang Y-C, Kim KM, Kim KJ, Rhee Y, Lim S-K (2011) Low serum vitamin D is associated with high risk of diabetes in Korean adults. The Journal of Nutrition. 141 (8): 1524-1528. doi: 10.3945/jn.111.139121
  41. Zemel MB (2002) Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. Journal of American College of Nutrition. 21 (2): 146S-151S. doi: 10.1080/07315724.2002.10719212

Submitted date:
12/24/2024

Reviewed date:
05/19/2025

Accepted date:
04/27/2025

Publication date:
05/10/2025

681fc239a95395232d6ec9d2 medjpps Articles
Links & Downloads

Mediterr J Pharm Pharm Sci

Share this page
Page Sections